Ligand ID: 5CH Drugbank ID: DB01628(Etoricoxib) Indication:For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.77A | 17.61 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.70A | 23.82 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.73A | 23.76 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 4 | THR B 198VAL B 204GLY B 109THR B 111 | 1.70A | 23.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 4 | THR C 198VAL C 204GLY C 109THR C 111 | 1.74A | 23.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 4 | THR D 198VAL D 204GLY D 109THR D 111 | 1.79A | 23.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.69A | 23.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 276VAL A 299GLY A 345THR A 344 | 1.65A | 15.47 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 393VAL A 398GLY A 671THR A 402 | 1.75A | 15.47 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 462VAL A 792GLY A 679THR A 680 | 1.76A | 15.47 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR A 240VAL A 90GLY A 107THR A 108 | 1.47A | 14.40 | NoneNoneNoneNAG A1317 (-3.7A) | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR B 240VAL B 90GLY B 107THR B 108 | 1.53A | 14.00 | NoneNoneNoneNAG B1303 ( 4.1A) | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR C 284VAL C 47GLY B 566THR B 573 | 1.30A | 14.00 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w41 | CR3022 FAB HEAVYCHAINSPIKE PROTEIN S1 (Homosapiens;SARS-CoV-2) | 4 / 4 | THR H 31VAL C 433GLY C 381THR C 430 | 1.70A | 18.02 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w61 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4364VAL B4369GLY B4305THR B4304 | 1.67A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w61 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4354VAL B4350GLY B4305THR B4304 | 1.68A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4354VAL D4350GLY D4305THR D4304 | 1.62A | 17.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4364VAL D4369GLY D4305THR D4304 | 1.74A | 17.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4364VAL B4369GLY B4305THR B4304 | 1.75A | 17.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4354VAL B4350GLY B4305THR B4304 | 1.63A | 17.63 | None | ||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4364VAL B4369GLY B4305THR B4304 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4354VAL D4350GLY D4305THR D4304 | 1.61A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4354VAL B4350GLY B4305THR B4304 | 1.61A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4364VAL D4369GLY D4305THR D4304 | 1.74A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4354VAL B4350GLY B4305THR B4304 | 1.62A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4354VAL D4350GLY D4305THR D4304 | 1.61A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4364VAL B4369GLY B4305THR B4304 | 1.76A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 4 | THR D4364VAL D4369GLY D4305THR D4304 | 1.74A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wq3 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4354VAL B4350GLY B4305THR B4304 | 1.69A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wq3 | NSP10 (SARS-CoV-2) | 4 / 4 | THR B4364VAL B4369GLY B4305THR B4304 | 1.73A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR A 376VAL A 511GLY A 431THR A 430 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR E 376VAL E 511GLY E 431THR E 430 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR E 376VAL E 511GLY E 431THR E 430 | 1.74A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.80A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR E 376VAL E 511GLY E 431THR E 430 | 1.74A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 4 | THR A 376VAL A 511GLY A 431THR A 430 | 1.75A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.77A | NoneNonePEG A 405 (-3.3A) CL A 406 ( 3.6A) | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.72A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7btf | NSP8 (SARS-CoV-2) | 4 / 4 | THR B 137VAL B 130GLY B 144THR B 145 | 1.73A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 276VAL A 299GLY A 345THR A 344 | 1.70A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 20VAL A 11GLY A 25THR A 26 | 1.55A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 4 | THR A 198VAL A 204GLY A 109THR A 111 | 1.71A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 276VAL A 299GLY A 345THR A 344 | 1.63A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 462VAL A 792GLY A 679THR A 680 | 1.76A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 393VAL A 398GLY A 671THR A 402 | 1.77A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 276VAL A 299GLY A 345THR A 344 | 1.63A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 4 | THR A 393VAL A 398GLY A 671THR A 402 | 1.72A | None | |||
![]() | 3CFL_A_5CHA693_1 (LACTOTRANSFERRIN) | 7bv2 | NSP8 (SARS-CoV-2) | 4 / 4 | THR B 137VAL B 130GLY B 144THR B 145 | 1.71A | None |